Repression of SARS-CoV-2 Induced Hyper-inflammation by Topoisomerase I Inhibition

Aug 22, 2022
MD4 Seminar Room, Level 2

📣 #IDTRPseminar

Another interesting talk will be on Monday, 22 August 2022, at 12 noon (Singapore Time). Everyone is welcome to join this in-person seminar at our MD4, Seminar Room Level 2 on “Repression of SARS-CoV-2 Induced Hyperinflammation by Topoisomerase I Inhibition” by Dr Jessica Ho. She will share her work in evaluating the role of Topoisomerase I (TOP1) in the control of excessive inflammation during SARS-CoV-2 infection.

#TOP1 #COVID #ResearchSeminar #InfectiousDiseasesTRP #NUSMedicine

Please note that registration is onsite only and the seminar will be recorded.

Biography:
Jessica Ho received her PhD at the Rockefeller University and subsequently did her initial postdoctoral training in the IMCB in A*STAR, Singapore. She is now currently a postdoctoral fellow in the Department of Microbiology at the Icahn School of Medicine at Mount Sinai in New York City, where she is a recipient of the Charles H. Revson Senior Fellowship in Biomedical Science. Her main research interest is in understanding epigenetic mechanisms that underlie host-pathogen interactions during viral disease.

More Seminar, Courses & Workshops

On-site

Host lipids define niche-specific colonisation of Salmonella

Biography Professor Ian Henderson is the Executive Director, Institute for …

On-site

Gut microbiome —keystone modifier of infectious immunity and opportunities for therapy

📣 #IDTRPseminar Abstract: The global recurrent threat of respiratory virus pandemics …

On-site

Advancements in Understanding and Combating Emerging Viral Diseases: Pathogenesis, Therapeutics, and Vaccine Development.

📣 #IDTRPseminar Abstract: Dengue, Zika, and chikungunya, well-known arboviruses, have caused …